| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113883.3.3616.200.110.102.3056 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.3056 |
| version | 20200711 |
| status | active |
| publisher | Clinical Architecture |
| name | COVID19ICD10CMValueSetAdrenalDisorders |
| title | COVID19 ICD10CM Value Set Adrenal Disorders |
| date | 2023-06-21T18:16:37-04:00 |
| experimental | false |
| Usages |
|
This value set contains 33 concepts
| Code | System | Display |
| E24 | http://hl7.org/fhir/sid/icd-10-cm | Cushing's syndrome |
| E24.0 | http://hl7.org/fhir/sid/icd-10-cm | Pituitary-dependent Cushing's disease |
| E24.1 | http://hl7.org/fhir/sid/icd-10-cm | Nelson's syndrome |
| E24.2 | http://hl7.org/fhir/sid/icd-10-cm | Drug-induced Cushing's syndrome |
| E24.3 | http://hl7.org/fhir/sid/icd-10-cm | Ectopic ACTH syndrome |
| E24.4 | http://hl7.org/fhir/sid/icd-10-cm | Alcohol-induced pseudo-Cushing's syndrome |
| E24.8 | http://hl7.org/fhir/sid/icd-10-cm | Other Cushing's syndrome |
| E24.9 | http://hl7.org/fhir/sid/icd-10-cm | Cushing's syndrome, unspecified |
| E25 | http://hl7.org/fhir/sid/icd-10-cm | Adrenogenital disorders |
| E25.0 | http://hl7.org/fhir/sid/icd-10-cm | Congenital adrenogenital disorders associated with enzyme deficiency |
| E25.8 | http://hl7.org/fhir/sid/icd-10-cm | Other adrenogenital disorders |
| E25.9 | http://hl7.org/fhir/sid/icd-10-cm | Adrenogenital disorder, unspecified |
| E26 | http://hl7.org/fhir/sid/icd-10-cm | Hyperaldosteronism |
| E26.0 | http://hl7.org/fhir/sid/icd-10-cm | Primary hyperaldosteronism |
| E26.01 | http://hl7.org/fhir/sid/icd-10-cm | Conn's syndrome |
| E26.02 | http://hl7.org/fhir/sid/icd-10-cm | Glucocorticoid-remediable aldosteronism |
| E26.09 | http://hl7.org/fhir/sid/icd-10-cm | Other primary hyperaldosteronism |
| E26.1 | http://hl7.org/fhir/sid/icd-10-cm | Secondary hyperaldosteronism |
| E26.8 | http://hl7.org/fhir/sid/icd-10-cm | Other hyperaldosteronism |
| E26.81 | http://hl7.org/fhir/sid/icd-10-cm | Bartter's syndrome |
| E26.89 | http://hl7.org/fhir/sid/icd-10-cm | Other hyperaldosteronism |
| E26.9 | http://hl7.org/fhir/sid/icd-10-cm | Hyperaldosteronism, unspecified |
| E27 | http://hl7.org/fhir/sid/icd-10-cm | Other disorders of adrenal gland |
| E27.0 | http://hl7.org/fhir/sid/icd-10-cm | Other adrenocortical overactivity |
| E27.1 | http://hl7.org/fhir/sid/icd-10-cm | Primary adrenocortical insufficiency |
| E27.2 | http://hl7.org/fhir/sid/icd-10-cm | Addisonian crisis |
| E27.3 | http://hl7.org/fhir/sid/icd-10-cm | Drug-induced adrenocortical insufficiency |
| E27.4 | http://hl7.org/fhir/sid/icd-10-cm | Other and unspecified adrenocortical insufficiency |
| E27.40 | http://hl7.org/fhir/sid/icd-10-cm | Unspecified adrenocortical insufficiency |
| E27.49 | http://hl7.org/fhir/sid/icd-10-cm | Other adrenocortical insufficiency |
| E27.5 | http://hl7.org/fhir/sid/icd-10-cm | Adrenomedullary hyperfunction |
| E27.8 | http://hl7.org/fhir/sid/icd-10-cm | Other specified disorders of adrenal gland |
| E27.9 | http://hl7.org/fhir/sid/icd-10-cm | Disorder of adrenal gland, unspecified |
Produced 08 Sep 2023